CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection.

Source:http://linkedlifedata.com/resource/pubmed/id/21098218

J. Immunol. 2011 Jan 1 186 1 508-15

Download in:

View as

General Info

PMID
21098218